SB CLINICAL CONSULTING

Alken ·KBO/BCE: BE 0793.757.928

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	20-03-2026	133 d early	2026-00061309
31-12-2024	31-07-2025	30-06-2025	31 d early	2025-00206769
31-12-2023	31-07-2024	21-06-2024	40 d early	2024-00152518

Metric	This company	Sector median	Position in the sector
Solvency	89.9%	55.5%	better than 90% of 4723 sector peers
Net result	€52k	€38k	better than 61% of 4722 sector peers
Equity	€252k	€64k	better than 87% of 4723 sector peers
Gross operating margin	€68k	€61k	better than 55% of 4715 sector peers
Total assets	€281k	€146k	better than 75% of 4723 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€281k
Fixed assets	21/28	€11k
Tangible fixed assets	22/27	€11k
Current assets	29/58	€270k
Amounts receivable within one year	40/41	€147k
Cash & bank	54/58	€121k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€281k
Equity	10/15	€252k
Contributions / capital	10/11	€10k
Reserves	13	€242k
Amounts payable	17/49	€28k
Amounts payable within one year	42/48	€28k
Trade debts payable within one year	44	€5k
Income statement
Gross operating margin	9900	€68k
Operating result	9901	€65k
Financial income	75	€3k
Financial charges	65	€535
Result before taxes	9903	€67k
Income taxes	67/77	€16k
Net result for the period	9904	€52k
Result to be appropriated	9905	€52k

Summary